Kukulska A, Gubała E, Turska M, Handkiewicz-Junak D, Czernik E, Deja R, Blamek S, Szpak S, Jarzab B
Zakładu Medycyny Nuklearnej i Endokrynologii Onkologicznej, Centrum Onkologii-Instytut im. M. Skłodowskiej-Curie, Oddział w Gliwicach.
Wiad Lek. 2001;54 Suppl 1:332-8.
The aim of this study was the assessment of diagnostic value of thyroglobulin serum measurement in patients with DTC during endogenous TSH stimulation. Thyroglobulin was measured by immunofluorometric method (Delfia-Wallac) in patients after combined surgery and I131 ablation. Predictive values for two threshold levels 10 and 30 ng/ml were compared. At 5 years follow up it has been demonstrated, that Tg values higher than 10 ng/ml were the true signals of DTC relapse only in 46% patients. Tg values higher than 30 ng/ml were associated with disease progression in 65% of patients. Thus, we accept Tg concentration of 30 ng/ml measured during endogenous TSH stimulation as a good cut-off limit for the detection of DTC progression. Reduction of this threshold up to 10 ng/ml is associated with the increased risk of false positive results.
本研究的目的是评估内源性促甲状腺激素(TSH)刺激下血清甲状腺球蛋白测量对分化型甲状腺癌(DTC)患者的诊断价值。采用免疫荧光法(Delfia-Wallac)对接受联合手术及碘-131消融治疗后的患者进行甲状腺球蛋白检测。比较了10 ng/ml和30 ng/ml两个阈值水平的预测价值。在5年随访中发现,甲状腺球蛋白(Tg)值高于10 ng/ml时,仅46%的患者为DTC复发的真实信号。Tg值高于30 ng/ml时,65%的患者与疾病进展相关。因此,我们认为内源性TSH刺激下测量的Tg浓度为30 ng/ml是检测DTC进展的良好临界值。将该阈值降至10 ng/ml会增加假阳性结果的风险。